Why Dynavax stock soared today

Shares of Dynavax Technologies (NASDAQ: DVAX) popped on Wednesday after the vaccine maker struck a deal to be acquired by ...

Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline

Dynavax's adult hepatitis B vaccine HEPLISAV-B is currently marketed in the US and is differentiated by its two-dose regimen over one month, which enables high levels of seroprotection faster than ...

Assessing Dynavax After a 42% Surge and Strong HEPLISAV B Growth in 2025

If you are wondering whether Dynavax Technologies at around $15 a share is still good value after its run, you are not alone. We are going to unpack that in a structured way. The stock has surged 42.5 ...

Nike, Omeros Corporation, Micron Technology, Intel And Dynavax Technologies: Why These 5 Stocks Are On Investors' Radars Today

The Dow Jones Industrial Average climbed 0.6% to 48,731.16, while the S&P 500 added 0.32% to close at 6,932.05.

Dynavax soars on deal news and other early market movers

Here are some of the stocks making notable moves in Wednesday's premarket action: Dynavax Technologies stock is up 37% after ...

Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline

Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline Paris, December 24, 2025.

Dynavax Technologies (DVAX) Shares Are Trending Overnight — Here's Why

Dynavax Technologies shares jumped more than 38% Wednesday after Sanofi announced a $15.50-per-share acquisition offer, valuing the company at roughly $2.2 billion.

Dynavax (DVAX) Rockets 38% on Sanofi $2-Billion Merger

We recently published 10 Stocks Lighting Up Market Ahead of Christmas. Dynavax Technologies Corp. (NASDAQ:DVAX) is one of the best performers on Wednesday. Dynavax soared by 38.19 percent on Wednesday ...